{"paper_id":"e1c9a9cf-a6e5-4417-a65c-10e763a83f07","body_text":"Zusammenfassung\nAbnorme uterine Blutungen (AUB) und Dysmenorrhö gehören zu den häufigsten Beschwerden in der Adoleszenz und den häufigsten Gründen für eine Arztkonsultation. Von AUB sind ca. 34–37 % der Jugendlichen betroffen, von einer Dysmenorrhö 50–75 % und 7–15 % geben starke Regelschmerzen mit Krankheitswert an. Der häufigste Grund einer AUB Jugendlicher ist die entwicklungsbedingte postmenarchale Anovulation, gefolgt von Gerinnungsstörungen. Die Dysmenorrhö ist bei Jugendlichen meist eine primäre Dysmenorrhö, d. h. ohne erkennbare organische Ursache. Endometriose ist wiederum der häufigste Grund für eine sekundäre Dysmenorrhö. Obwohl Blutungsstörungen die Lebensqualität erheblich einschränken können, vergeht oft eine lange Zeit, bis eine adäquate Diagnostik und Therapie erfolgen. Sicher ist dies auch eine Folge von Scham und Bagatellisierung von Regelbeschwerden. Einmal adäquat diagnostiziert sind Blutungsstörungen in den meisten Fällen jedoch gut behandelbar.\nAbstract\nAbnormal uterine bleeding (AUB) and dysmenorrhea are among the most frequent complaints in adolescent girls and one of the most frequent reasons for a medical consultation. Approximately a 34–37% of adolescent women are affected, 50–75% suffer from dysmenorrhea and 7–15% from severe period pains, which all can significantly affect the quality of life. The most common cause for AUB is a development-related anovulation during the first 2–3 years after menarche, followed by coagulation disorders. Most adolescents experiencing dysmenorrhea have primary dysmenorrhea, i.e. with no recognizable organic cause. In contrast, endometriosis is the most frequent reason for a secondary dysmenorrhea. Although bleeding disorders can lead to a significant impairment of the quality of life, it often takes a long time until adequate diagnosis and treatment are initiated. This is certainly also due to embarrassment or trivialization of menstrual problems. Nevertheless, once adequately diagnosed AUB and dysmenorrhea can be well treated in most cases.\nSimilar content being viewed by others\nLiteratur\nACOG Committee Opinion No. 651 (2015) Menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Obstet Gynecol 126(6):e143–e146\nACOG Committee Opinion 785 (2019) Screening and management of bleeding disorders in adolescents with heavy menstrual bleeding. Obstet Gynecol 134(3):e71–e83\nAltshuler AL, Hillard PJ (2014) Menstrual suppression for adolescents. Curr Opin Obstet Gynecol 26(5):323–331\nBatt RE, Mitwally MFM (2003) Endometriosis from thelarche to midteens: pathogenesis and prognosis, prevention and pedagogy. J Pediatr Adolesc Gynecol 16:337–347\nBecker CM, Gattrell WT, Gude K, Singh SS (2017) Reevaluating response and failure of medical treatment of endometriosis: a systematic review. Fertil Steril 108(1):125–136\nBiberoglu KO, Behrman SJ (1981) Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness. Am J Obstet Gynecol 139(6):645–654\nBofill Rodriguez M, Lethaby A, Farquhar C (2019) Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 9:CD4000. https://doi.org/10.1002/14651858.CD000400.pub4\nCasper RF (2017) Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertil Steril 107(3):533–536\nCreatsas GE, Deligeooglou E, Zachari A et al (1990) Prostaglandins: PGF2α, PGE2, 6‑keto-PGI α and TGB serum levels in dysmenorrhoeic adolescents before, during and after treatment with oral contraception. Eur J Obstet Gynecol Reprod Biol 36(3):292–298\nDeligoroglou E, Karountzos V, Creatsas GK (2013) Abnormal uterine bleeding and dysfunctional uterine bleeding in pediatric and adolescent gynecology. Gynecol Endocrinol 29(1):74–78\nDeligoroglou E, Creatsas GK (2015) Dysfunctional uterine bleeding as an early sign of polycystic ovary syndrome during adolescence. Minerva Ginecol 67(4):375–381\nDilley A, Drews C, Miller C et al (2001) Von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstet Gynecol 97(4):630–636\nFraser IS, Critchley HO, Munro MG, Border M (2007) A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Fertil Steril 87(3):466–476\nFriberg B, Ornö AK, Lindgren A, Lethagen S (2006) Bleedings disorders among young women: a population-based prevalence study. Acta Obstet Gynecol Scand 85(2):200–206\nGille G, Layer C, Hinzpeter B (2010) Identität im Fluss – Menstruationserleben junger Mädchen. Gynäkologe 43:87–94\nGoeckenjan M, Gabrys M (2020) Zyklusstörungen im Jugendalter. Korasion 2020(04):X100–X105\nGreil H, Kahl H (2005) Assessment of developmental age: cross-sectional analysis of secondary sexual characteristics. Anthropol Anz 63(1):63–75\nHewitt G (2020) Dysmenorrhoea and endometriosis: diagnosis and management in adolescents. Clin Obstet Gynecol 63(3):536–543\nHudelist G, Fritzer N, Thomas A, Niehues C, Oppelt P, Haas D, Tammaa A, Salzer H (2012) Diagnostic delay for endometriosis in Austria and Germany: causes and possible consequences. Hum Reprod 27(12):3412–3416\nJatlaoui TC, Riley HEM, Curtis KM (2017) The safety of intrauterine devices among young women: a systematic review. Contraception 95(1):17–39\nJensen JT (2019) Evaluation of a new estradiol oral contraceptive: estradiol valerat and dienogest. Expert Opin Pharmacother 11(7):1147–1157\nKlein JR, Litt LF (1981) Epidemiology of adolescent dysmenorrhea. Pediatrics 68:661–664\nLaufer MR, Goitein L, Bush M, Cramer DW, Emans SJ (1997) Prevalence of endometriosis in adolescent girls with chronic pelvic pain not responding to conventional therapy. J Pediatr Adolesc Gynecol 10(4):199–202\nLindh I, Ellström AA, Milsom I (2012) The effect of combined oral contraceptives and age on dysmenorrhea: an epidemiological study. Hum Reprod 27(3):676–682\nMarjoribanks J, Proctor M, Farquhar C, Derks RS (2010) Nonsteroidal anti-inflammatory drugs for dysmenorrhea. Cochrane Database Syst Rev 1:CD1751\nMunro MG, Critchley HO, Border MS, Fraser IS, FIGO Working Group on Menstrual Disorders (2011) FIGO classification system (PALM-COIEN) for cases of abnormal uterine bleeding in non gravid women of reproductive age. Int J Gynaecol Obstet 113(1):3–13\nPattanittum P, Kunyanone N, Brown J, Sangkomkamhang US, Barnes J, Seyfoddin V, Marjoribanks J (2016) Dietary supplements for dysmenorrhea. Cochrane Database Syst Rev 3:CD1214\nRees MCP, Di Marzo JR, Tippins JR (1987) Leukotriens release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhea and menorrhagia. J Endocrinol 113:291–295\nSchoep ME, Niboer TE, van der Zanden M, Braat DDM, Nap AW (2019) The impact of menstrual symptoms on everyday life: a survey among 42.879 women. Am J Obstet Gynecol 220:569.e1–569.e7\nSkovlund CW, Mørch LS, Kessing LV, Lidegaard Ø (2016) Association of hormonal contraception with depression. JAMA Psychiatry 73(11):1154–1162\nSmorgick N, As-Sanie S (2018) Pelvic pain in adolescents. Semin Reprod Med 36:116–122\nStravoulis AI, Saridogan E, Creighton SM, Cutner AS (2005) Laparoscopic treatment of endometriosis in teenagers. Eur J Obstet Gynecol 125:248–250\nUgur M, Turan C, Mugan T et al (1995) Endometriosis is associated with muellerian anomalies. Gynecol Obstet Invest 40:261–264\nVinogradova Y, Coupland C, Hippisley-Cox J (2015) Use of combined oral contraceptives and risk of venous thromboembolism: hested case-control studies using the QResearch and CPRD databases. BMJ 350:h2135\nWitchel SF, Oberfield SE, Peña AS (2019) Polycystic ovary syndrome: pathophysiology, presentation and treatment with emphasis on adolescent girls. J Endocr Soc 3(8):1545–1573\nWorly BL, Gur TL, Schaffir J (2018) The relationship between progestin hormonal contraception and depression: a systematic review. Contraception 97(6):478–498\nZannoni L, Giorgi M, Spagnolo E, Montanari G, Villa G, Seracchioli R (2014) Dysmenorrhea, absenteeism from school, and symptoms suspicious for endometriosis in adolescents. J Pediatr Adolesc Gynecol 27:258–265\nAuthor information\nAuthors and Affiliations\nCorresponding author\nEthics declarations\nInteressenkonflikt\nJ. Bartley ist Referentin für die Firmen Gedeon Richter, Jenapharm und Merck/Serono. I. Voss-Heine gibt an, dass kein Interessenkonflikt besteht.\nFür diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.\nAdditional information\nRedaktion\nGisela Gille, Lüneburg\nKatrin Schaudig, Hamburg\nAnneliese Schwenkhagen, Hamburg\nQR-Code scannen & Beitrag online lesen\nRights and permissions\nAbout this article\nCite this article\nBartley, J., Voss-Heine, I. Blutungsstörungen, Dysmenorrhö und Endometriose im Jugendalter. Gynäkologe 54, 640–649 (2021). https://doi.org/10.1007/s00129-021-04842-0\nAccepted:\nPublished:\nVersion of record:\nIssue date:\nDOI: https://doi.org/10.1007/s00129-021-04842-0","source_license":"CC0","license_restricted":false}